Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

Top hair loss treatment providers, like Hims, use proprietary blends of Rx ... Consult a doctor as some treatment types suited for men may not be suitable for women and vice versa.

Fintel reports that on January 10, 2025, Citigroup downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Neutral ...

Fintel reports that on January 7, 2025, BTIG initiated coverage of Hims & Hers Health (NYSE:HIMS) with a Buy recommendation.

the analyst tells investors in a research note. BTIG expects Hims’ revenue growth and demand for obesity health products to remain robust.

A core issue lies in the anticipated decline of HIMS’ GLP-1 revenues, with Citi projecting a sharp drop from $400 million in FY2025 to $135 million. This decline is linked to the FDA’s recent ...

Analyst Ryan MacDonald of Needham maintained a Buy rating on Hims & Hers Health (HIMS – Research Report), boosting the price target to ...

In recent trading, shares of Hims & Hers Health Inc (Symbol: HIMS) have crossed above the average analyst 12-month target price of $25.36, changing hands for $26.63/share. When a stock reaches the ...

Hims & Hers Health has seen its stock drop 21% over the past month. The pullback is driven by regulatory updates from the FDA regarding tirzepatide injection shortages. Get 5 New Stock ...